United States Pharmacopeia (USP) Safety Review of <i>Gamma</i>-Aminobutyric Acid (GABA)
<i>Gamma</i>-amino butyric acid (GABA) is marketed in the U.S. as a dietary supplement. USP conducted a comprehensive safety evaluation of GABA by assessing clinical studies, adverse event information, and toxicology data. Clinical studies investigated the effect of pure GABA as a dietar...
Main Authors: | Hellen A. Oketch-Rabah, Emily F. Madden, Amy L. Roe, Joseph M. Betz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/8/2742 |
Similar Items
-
Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review
by: Piril Hepsomali, et al.
Published: (2020-09-01) -
γ-amino butyric acid (GABA) level as an overall survival risk factor in breast cancer
by: Anna Brzozowska, et al.
Published: (2017-09-01) -
Genomic Comparison of <i>Lactobacillus casei</i> AP and <i>Lactobacillus plantarum</i> DR131 with Emphasis on the Butyric Acid Biosynthetic Pathways
by: Widodo Widodo, et al.
Published: (2021-02-01) -
Levofloxacin-induced acute anxiety and insomnia
by: Arun Kandasamy, et al.
Published: (2012-05-01) -
Free Amino Acids in Three <i>Pleurotus</i> Species Cultivated on Agricultural and Agro-Industrial By-Products
by: Dimitra Tagkouli, et al.
Published: (2020-09-01)